Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Conference News ACC 2023

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

L.A. McKeown

March 10, 2023

Presentation Fellows 2021

STEMI PCI Clot and No-Reflow

Presenter: Dharam J. Kumbhani

May 09, 2021

News Daily News

Observational Study Supports Continuing Oral Anticoagulation During PCI

Michael O'Riordan

April 06, 2021

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

News Conference News TCT 2019

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Todd Neale

September 28, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

News Daily News

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Michael O'Riordan

January 15, 2019

Presentation TCT 2018

Case Presentation #1: No Reflow After Primary PCI

Presenter: Morton J. Kern, Graham Nichol, Sorin J. Brener, Rajiv Gulati, Neal S. Kleiman, Dharam J. Kumbhani, Divaka Perera, Marco A. Perin

September 24, 2018

Presentation iASSESS 2017

STEMI: Treatment Strategies, Drugs And Devices

Presenter: Dharam J. Kumbhani

August 24, 2017

News Daily News

Almost Half of US Operators Do Under 50 PCIs Per Year: Does It Matter?

Shelley Wood

June 15, 2017

News Daily News

Hospital-Level PCI Volume May Not Have a Strong Influence on Outcomes, UK Study Suggests

Todd Neale

March 27, 2017

Presentation TCT 2016

STEMI Treatment Strategies: Drugs and Devices

Presenter: Tayo A. Addo, Dharam J. Kumbhani

October 30, 2016

Advertisement

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

TCTMD’s Top 10 Most Popular Stories for October 2025

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

STEMI PCI Clot and No-Reflow

Observational Study Supports Continuing Oral Anticoagulation During PCI

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Case Presentation #1: No Reflow After Primary PCI

STEMI: Treatment Strategies, Drugs And Devices

Almost Half of US Operators Do Under 50 PCIs Per Year: Does It Matter?

Hospital-Level PCI Volume May Not Have a Strong Influence on Outcomes, UK Study Suggests

STEMI Treatment Strategies: Drugs and Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content